Compare Hewlett Packard Enterprise Co (HPE) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hewlett Packard Enterprise Co vs Vir Biotechnology Inc. Common Stock — how do they compare? Hewlett Packard Enterprise Co trades at $57.52 (market cap $83.78B), while Vir Biotechnology Inc. Common Stock trades at $10.51 (market cap $1.76B). The key difference: Hewlett Packard Enterprise Co is far larger — about 47.6× Vir Biotechnology Inc. Common Stock's market cap, and Hewlett Packard Enterprise Co pays a 0.9% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hewlett Packard Enterprise Co for 34 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| HPE | VIR | |
|---|---|---|
Market Cap | $83.78B | $1.76B |
Volume | 21,753,370 | 2,764,948 |
Sector | Technology | Health |
52-Week High | $73.46 | $11.78 |
52-Week Low | $20.01 | $5.12 |
Typical Hold Time | 34 Days | 0 Days |
Enterprise Value | $97.80B | $1.32B |
Dividend Yield | 0.9% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HPE is trading at $68.80, down 2.13% today but remains near record highs following strong AI infrastructure demand. The stock has gained over 160% year-over-year and recently received multiple analyst upgrades. Recent earnings show consistent beats with Q2 2026 EPS of $1.11 exceeding expectations. Technical indicators suggest bullish momentum with support at $68 and resistance at $72. The company secured a $1.2 billion AI server order from Vultr and raised its networking outlook.
HPE presents a compelling growth story driven by AI infrastructure demand, with analyst consensus at $70.00 target price and 45% buy ratings. Key risks include execution challenges in integrating Juniper Networks and potential margin pressure from increased competition. The stock's elevated P/E ratio of 32.53 requires continued strong earnings growth to justify valuation. Recent institutional upgrades reflect confidence in HPE's AI positioning.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hewlett Packard Enterprise Co
Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises. Its primary product lines are compute servers, storage arrays, and networking equipment.
Read more on HPE →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
